Imran Nasrullah
Imran Nasrullah is a biopharmaceutical leader known for his role in leading Bayer's Collaborate to Cure Hub in the US for BD&L, focusing on licensing, collaboration, and ecosystem activation.
With a track record in business development, alliance management, and licensing activities in various fields such as diagnostics, personalized medicine, therapeutics, and technology platforms, Imran has demonstrated his ability to drive external innovation and create impactful partnerships.
Imran excels in negotiation, execution of complex agreements, and enhancing R&D performance through strategic acquisitions and collaborations with biopharmaceutical, academic, and government entities.
His extensive experience includes roles at reputable organizations like Boehringer Ingelheim, Massbio, Genzyme Genetics, Millennium Pharmaceuticals, Dana Farber Cancer Center, and Mayo Clinic, where he has contributed significantly to driving innovation and fostering entrepreneurship.
Imran's industrial expertise spans areas such as intrapreneurship, search & evaluation, business development, licensing, negotiation, transactions, collaboration, and alliance formation & management, particularly in inflammation, oncology, metabolics therapeutics, and diagnostics.
He has a diverse educational background, holding a J.D. in Intellectual Property and Licensing from Suffolk University Law School, a Master of Science in Integrative Physiology from the University of Colorado, and a Bachelor of Science in Exercise Physiology from the University of Massachusetts, Amherst.
